Kidney Cancer Linked to Kidney Stones
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
Kidney Week 2014
Study Reveals Advantages of Non-Calcareous Phosphate Binders
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Calciphylaxis Risk Lower in Cinacalcet Users
Calciphylaxis was 75% less likely to develop in patients who received the drug rather than placebo.
Diabetic Nephropathy More Common Than Previously Thought
Researchers in the Netherlands report results from an autopsy study of diabetic nephropathy patients.
Ferric Citrate Controls Phosphorus, Cuts ESA Use
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
Insulin Resistance Linked to High Phosphorus in Maintenance Hemodialysis (MHD) Patients
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
ESA Use May Lower Risk of Transfusion
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Higher Phosphorus, Cardiovascular Disease (CVD) Not Linked in Kidney Disease (CKD) Patients
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Post-Op Acute Kidney Injury Not Prevented by Aspirin, Clonidine
Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension in acute kidney injury (AKI).
Earlier Use of ESAs Benefits Non-Dialysis Kidney Disease (CKD) Patients
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Week 2014 Anemia
Loading... 
Loading...